NBIX

NASDAQStock

Neurocrine Biosciences, Inc.

$129.78+1.65 (+1.29%)

52-Week Range

$87.54

$155.63

Key Stats

Market Cap

13.0B

P/E Ratio

27.78

Dividend Yield

—

Beta

0.36

Volume

646.5K

Avg Volume

1.1M

Performance

+2.95%

-17.06%

-9.31%

YTD

-9.12%

+14.60%

+35.58%

+35.10%

Price Chart

ETF Exposure

NBIX is held by 380 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
WEBC.DE	Amundi MSCI North America ESG Broad Transition UCITS ETF Dist	0.01%	372	$41K	$568.7M	0.15%
DFAS	Dimensional - US Small Cap ETF	0.01%	6,190	$791K	$12.65B	0.26%
EEWG.L	iShares MSCI World CTB Enhanced ESG UCITS ETF	0.01%	2,907	$282K	$822.8M	0.20%
EMND.DE	iShares MSCI World CTB Enhanced ESG UCITS ETF	0.01%	2,907	$327K	$953.0M	0.20%
GVUS	Goldman Sachs MarketBeta Russell 1000 Value Equity ETF	0.01%	179	$23K	$402.0M	0.12%
IWD	iShares Russell 1000 Value ETF	0.01%	30,814	$4.0M	$68.78B	0.18%
R1VL.L	iShares Russell 1000 Value UCITS ETF	0.01%	226	$29K	$449.3M	0.18%
VONV	Vanguard Russell 1000 Value ETF	0.01%	7,453	$1.0M	$16.60B	0.06%
AOA	iShares Core 80/20 Aggressive Allocation ETF	0.01%	2,187	$283K	$2.84B	0.19%
ITDE	iShares LifePath Target Date 2045 ETF	0.01%	45	$6K	$63.0M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.01%	46	$6K	$57.9M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.01%	36	$5K	$42.1M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.01%	24	$3K	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.01%	18	$2K	$21.0M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.01%	8	$1K	$9.3M	0.12%
MMTM	State Street SPDR S&P 1500 Momentum Tilt ETF	0.01%	63	$8K	$163.7M	0.12%
AOR	iShares Core 60/40 Balanced Allocation ETF	0.00%	1,906	$247K	$3.23B	0.20%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	50	$7K	$80.4M	0.11%
REVS	Columbia Research Enhanced Value ETF	0.00%	62	$8K	$213.5M	0.20%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	154	$28K	$820.6M	0.25%
AOM	iShares Core 40/60 Moderate Allocation ETF	0.00%	660	$85K	$1.67B	0.20%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	27	$4K	$60.6M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	43	$6K	$80.3M	0.10%
MAGU.AS	iShares Growth Portfolio UCITS ETF	0.00%	46	$6K	$1.1M	0.25%
AOK	iShares Core 30/70 Conservative Allocation ETF	0.00%	215	$28K	$725.0M	0.20%
IRTR	iShares LifePath Retirement ETF	0.00%	19	$2K	$51.7M	0.08%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	26	$5K	$337.7M	0.32%
AVTM	Avantis Total Equity Markets ETF 1	0.00%	55	$7K	$803.1M	0.23%
IQSM	NYLI Candriam U.S. Mid Cap Equity ETF	0.00%	9,951	$0	$207.8M	0.15%
LRND	NYLI U.S. Large Cap R&D Leaders ETF	0.00%	63	$0	$68.3M	0.14%

PreviousPage 8 of 8

About NBIX ETF Exposure

Neurocrine Biosciences, Inc. (NBIX) is held by 380 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 13.0B, NBIX is a widely held institutional stock. The stock currently trades at $129.78. Investors can gain exposure to NBIX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NBIX, sorted by portfolio weight.